BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22752961)

  • 1. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.
    González F; Sia CL; Stanczyk FZ; Blair HE; Krupa ME
    Endocrine; 2012 Dec; 42(3):726-35. PubMed ID: 22752961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose and lipopolysaccharide regulate proatherogenic cytokine release from mononuclear cells in polycystic ovary syndrome.
    González F; Kirwan JP; Rote NS; Minium J; O'Leary VB
    J Reprod Immunol; 2014 Jun; 103():38-44. PubMed ID: 24576416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of proatherogenic inflammation in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    Metabolism; 2009 Jul; 58(7):954-62. PubMed ID: 19375763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polycystic ovary syndrome per se is not associated with increased chronic inflammation.
    Möhlig M; Spranger J; Osterhoff M; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Eur J Endocrinol; 2004 Apr; 150(4):525-32. PubMed ID: 15080783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
    González F; Considine RV; Abdelhadi OA; Acton AJ
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.
    Nehir Aytan A; Bastu E; Demiral I; Bulut H; Dogan M; Buyru F
    Gynecol Endocrinol; 2016 Sep; 32(9):709-713. PubMed ID: 26951881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.
    Shorakae S; Ranasinha S; Abell S; Lambert G; Lambert E; de Courten B; Teede H
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):628-633. PubMed ID: 29992612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome.
    González F; Considine RV; Abdelhadi OA; Xue J; Acton AJ
    Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E689-E701. PubMed ID: 34632798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.
    González F; Kirwan JP; Rote NS; Minium J
    Am J Physiol Endocrinol Metab; 2013 Feb; 304(4):E375-83. PubMed ID: 23249695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome.
    Berbrier DE; Leone CA; Adler TE; Bender JR; Taylor HS; Stachenfeld NS; Usselman CW
    J Appl Physiol (1985); 2023 Apr; 134(4):868-878. PubMed ID: 36861670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels.
    Tropeano G; Vuolo IP; Lucisano A; Liberale L; Barini A; Carfagna P; Caroli G; Menini E; dell'Acqua S
    J Endocrinol Invest; 1996 Mar; 19(3):139-45. PubMed ID: 8743278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?
    Li S; Chu Q; Ma J; Sun Y; Tao T; Huang R; Liao Y; Yue J; Zheng J; Wang L; Xue X; Zhu M; Kang X; Yin H; Liu W
    J Clin Endocrinol Metab; 2017 Mar; 102(3):810-821. PubMed ID: 27886515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
    Usselman CW; Yarovinsky TO; Steele FE; Leone CA; Taylor HS; Bender JR; Stachenfeld NS
    J Physiol; 2019 Jun; 597(11):2853-2865. PubMed ID: 30847930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hyperandrogenism in lean reproductive-age women stimulates proatherogenic inflammation.
    González F; Sreekumaran Nair K; Basal E; Bearson DM; Schimke JM; Blair HE
    Horm Metab Res; 2015 Jun; 47(6):439-44. PubMed ID: 25230323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Weaver AL; Kirwan JP
    Cytokine; 2010 Sep; 51(3):240-4. PubMed ID: 20598902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.